Biomaker evaluation for major adverse cardiovascular event development in patients undergoing cardiac Surgery

The postoperative period of cardiac surgery (CS) is associated with the development of major adverse cardiovascular events (MACEs). However, the evaluation of MACE after CS by means of biomarkers is poorly developed. We aimed to evaluate postoperative biomarkers that could be associated with MACE.

Guardado en:

Detalles Bibliográficos
Autores principales:	Imperiali Claudia E., Lopez-Delgado Juan C., Dastis-Arias Macarena, Sanchez-Navarro Lourdes
Formato:	article
Lenguaje:	EN ES
Publicado:	De Gruyter 2020
Materias:	biomarkers cardiac surgery outcome Medical technology R855-855.5
Acceso en línea:	https://doaj.org/article/4e3a432088204ee2b2c3ea069b3113a7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:4e3a432088204ee2b2c3ea069b3113a7
record_format	dspace
spelling	oai:doaj.org-article:4e3a432088204ee2b2c3ea069b3113a72021-12-05T14:10:39ZBiomaker evaluation for major adverse cardiovascular event development in patients undergoing cardiac Surgery2628-491X10.1515/almed-2020-0031https://doaj.org/article/4e3a432088204ee2b2c3ea069b3113a72020-07-01T00:00:00Zhttps://doi.org/10.1515/almed-2020-0031https://doaj.org/toc/2628-491XThe postoperative period of cardiac surgery (CS) is associated with the development of major adverse cardiovascular events (MACEs). However, the evaluation of MACE after CS by means of biomarkers is poorly developed. We aimed to evaluate postoperative biomarkers that could be associated with MACE.Imperiali Claudia E.Lopez-Delgado Juan C.Dastis-Arias MacarenaSanchez-Navarro LourdesDe Gruyterarticlebiomarkerscardiac surgeryoutcomeMedical technologyR855-855.5ENESAdvances in Laboratory Medicine, Vol 1, Iss 4, Pp 597-34 (2020)
institution	DOAJ
collection	DOAJ
language	EN ES
topic	biomarkers cardiac surgery outcome Medical technology R855-855.5
spellingShingle	biomarkers cardiac surgery outcome Medical technology R855-855.5 Imperiali Claudia E. Lopez-Delgado Juan C. Dastis-Arias Macarena Sanchez-Navarro Lourdes Biomaker evaluation for major adverse cardiovascular event development in patients undergoing cardiac Surgery
description	The postoperative period of cardiac surgery (CS) is associated with the development of major adverse cardiovascular events (MACEs). However, the evaluation of MACE after CS by means of biomarkers is poorly developed. We aimed to evaluate postoperative biomarkers that could be associated with MACE.
format	article
author	Imperiali Claudia E. Lopez-Delgado Juan C. Dastis-Arias Macarena Sanchez-Navarro Lourdes
author_facet	Imperiali Claudia E. Lopez-Delgado Juan C. Dastis-Arias Macarena Sanchez-Navarro Lourdes
author_sort	Imperiali Claudia E.
title	Biomaker evaluation for major adverse cardiovascular event development in patients undergoing cardiac Surgery
title_short	Biomaker evaluation for major adverse cardiovascular event development in patients undergoing cardiac Surgery
title_full	Biomaker evaluation for major adverse cardiovascular event development in patients undergoing cardiac Surgery
title_fullStr	Biomaker evaluation for major adverse cardiovascular event development in patients undergoing cardiac Surgery
title_full_unstemmed	Biomaker evaluation for major adverse cardiovascular event development in patients undergoing cardiac Surgery
title_sort	biomaker evaluation for major adverse cardiovascular event development in patients undergoing cardiac surgery
publisher	De Gruyter
publishDate	2020
url	https://doaj.org/article/4e3a432088204ee2b2c3ea069b3113a7
work_keys_str_mv	AT imperialiclaudiae biomakerevaluationformajoradversecardiovasculareventdevelopmentinpatientsundergoingcardiacsurgery AT lopezdelgadojuanc biomakerevaluationformajoradversecardiovasculareventdevelopmentinpatientsundergoingcardiacsurgery AT dastisariasmacarena biomakerevaluationformajoradversecardiovasculareventdevelopmentinpatientsundergoingcardiacsurgery AT sancheznavarrolourdes biomakerevaluationformajoradversecardiovasculareventdevelopmentinpatientsundergoingcardiacsurgery
_version_	1718371839215927296

Biomaker evaluation for major adverse cardiovascular event development in patients undergoing cardiac Surgery

Ejemplares similares